
Overview
Mylene Leheudre-Aubertin practices in Montreal, Canada. Ms. Leheudre-Aubertin is rated as an Experienced expert by MediFind in the treatment of Spasticity. Her top areas of expertise are Muscle Atrophy, Menopause, Obesity, Spastic Ataxia Charlevoix-Saguenay Type, and Hormone Replacement Therapy (HRT).
Her clinical research consists of co-authoring 143 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Spasticity.
Locations
Montreal, QC, Canada
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MenopauseMs. Leheudre-Aubertin isAdvanced. Learn about Menopause.
- Muscle AtrophyMs. Leheudre-Aubertin isAdvanced. Learn about Muscle Atrophy.
- ObesityMs. Leheudre-Aubertin isAdvanced. Learn about Obesity.
- Experienced
- Abdominal Obesity Metabolic SyndromeMs. Leheudre-Aubertin isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- COVID-19Ms. Leheudre-Aubertin isExperienced. Learn about COVID-19.
- Hormone Replacement Therapy (HRT)Ms. Leheudre-Aubertin isExperienced. Learn about Hormone Replacement Therapy (HRT).
- Metabolic SyndromeMs. Leheudre-Aubertin isExperienced. Learn about Metabolic Syndrome.
- OsteoporosisMs. Leheudre-Aubertin isExperienced. Learn about Osteoporosis.
- Postmenopausal OsteoporosisMs. Leheudre-Aubertin isExperienced. Learn about Postmenopausal Osteoporosis.